The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans

The extant jawless vertebrates, represented by lampreys and hagfish, are the oldest group of vertebrates and provide an interesting genomic evolutionary pivot point between invertebrates and jawed vertebrates. Through genome analysis of one of these jawless vertebrates, the Japanese lamprey (Lethent...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Venkatesh, Byrappa, Lane, David P., Coffill, Cynthia R., Lee, Alison P., Siau, Jia Wei, Chee, Sharon M., Joseph, Thomas L., Tan, Yaw Sing, Madhumalar, Arumugam, Tay, Boon-Hui, Brenner, Sydney, Verma, Chandra Shekhar, Ghadessy, Farid J.
Kolejni autorzy:	School of Biological Sciences
Format:	Journal Article
Język:	English
Wydane:	2016
Hasła przedmiotowe:	P53 Mdm2 Mdm4 Evolution Lamprey
Dostęp online:	https://hdl.handle.net/10356/82782 http://hdl.handle.net/10220/40297

Podobne zapisy

Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation
od: Rati Lama, i wsp.
Wydane: (2024-12-01)

Modulating the p53-MDM2 pathway
od: Iman Ramli, i wsp.
Wydane: (2024-11-01)

Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells
od: Rati Lama, i wsp.
Wydane: (2025-01-01)

MDM2 inhibitors in cancer immunotherapy: Current status and perspective
od: Qinru Zeng, i wsp.
Wydane: (2024-11-01)

The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation
od: Adel S. Girgis, i wsp.
Wydane: (2025-02-01)

Primary liposarcoma of the uterus with MDM2 negative
od: Shufei Wei, i wsp.
Wydane: (2024-12-01)

Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
od: Charmy Twala, i wsp.
Wydane: (2025-01-01)

Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53
od: Zhaofeng Liu, i wsp.
Wydane: (2024-02-01)

CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway
od: Ming Xu, i wsp.
Wydane: (2024-04-01)

RETRACTED: Mutual regulation of MDM4 and TOP2A in cancer cell proliferation
od: Tao Liu, i wsp.
Wydane: (2019-05-01)

دراسة مناعية كيميانسيجية تراجعية لتعبيرية البروتين MDM2 في بعض أورام الغدد اللعابية
od: حبيب السلوم
Wydane: (2024-09-01)

Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach
od: Keting Li, i wsp.
Wydane: (2024-12-01)

MDM2 Is Essential to Maintain the Homeostasis of Epithelial Cells by Targeting p53
od: Su Wang, i wsp.
Wydane: (2024-08-01)

Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?
od: Wei Wang, i wsp.
Wydane: (2025-03-01)

Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells
od: Kinga Wilkus-Adamczyk, i wsp.
Wydane: (2024-12-01)

Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus
od: A.H. AlBosale, i wsp.
Wydane: (2022-03-01)

Two-mode Single-channel 1 000 km MDM Transmission based on FMF
od: WANG Xinyi, i wsp.
Wydane: (2024-08-01)

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma
od: Jiro Ichikawa, i wsp.
Wydane: (2024-10-01)

Ribosomal Protein S4 X-Linked as a Novel Modulator of MDM2 Stability by Suppressing MDM2 Auto-Ubiquitination and SCF Complex-Mediated Ubiquitination
od: Satsuki Ryu, i wsp.
Wydane: (2024-07-01)

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy
od: Dantong Sun, i wsp.
Wydane: (2024-01-01)

Dual EMCV-IRES-integrated dengue virus can express an exogenous gene and cellular Mdm2 integration suppresses the dengue viral replication
od: Tadahisa Teramoto
Wydane: (2025-01-01)

The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy
od: Nora D. Hatletvedt, i wsp.
Wydane: (2025-02-01)

Synthesis, characterization, and anti-cancer potential of novel p53-mediated Mdm2 and Pirh2 modulators: an integrated In silico and In vitro approach
od: Sarfaraj Niazi, i wsp.
Wydane: (2024-07-01)

Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer
od: Immacolata Maietta, i wsp.
Wydane: (2024-09-01)

Performance Research of MDM System based on Bit Interleaved Polar Coded Modulation
od: HU Wei-guo, i wsp.
Wydane: (2022-08-01)

Multi Domain Matrix (MDM) of the Vertical Hydrogenerator
od: Ivan Triplat, i wsp.
Wydane: (2019-01-01)

Low-Grade Uterine Adenosarcoma with Overexpression of MDM2 and CDK4 by Immunohistochemistry: A Case Report and Literature Review
od: Yumiko Miyazaki, i wsp.
Wydane: (2024-10-01)

Study on the design, synthesis, and activity of anti-tumor staple peptides targeting MDM2/MDMX
od: Jian Yang, i wsp.
Wydane: (2024-06-01)

MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers
od: Jie Liu, i wsp.
Wydane: (2024-01-01)

Case report: An atypical case of uterine adenosarcoma with extensive bizarre stromal cells and amplification of MDM2
od: Xiaoling Xiao, i wsp.
Wydane: (2024-03-01)

Anticancer activity of Aucklandia costus Falc. terpenes: Targeting MDM2 protein inhibition for therapeutic advancements
od: Theresia Indah Budhy, i wsp.
Wydane: (2024-07-01)

USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2
od: Peng Lu, i wsp.
Wydane: (2024-11-01)

The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis
od: O. Bulgakova, i wsp.
Wydane: (2020-12-01)

BRD4 promotes gouty arthritis through MDM2-mediated PPARγ degradation and pyroptosis
od: Xiaoxia Xu, i wsp.
Wydane: (2024-05-01)

Overdiagnosis of atypical lipomatous tumors/well-differentiated liposarcomas by morphological diagnosis using only HE stained specimens: a case–control study with MDM2/CDK4 immunostaining and MDM2/CDK4 fluorescence in situ hybridization
od: Kentaro Nomura, i wsp.
Wydane: (2024-11-01)

MDM2 drives resistance to Osimertinib by contextually disrupting FBW7-mediated destruction of MCL-1 protein in EGFR mutant NSCLC
od: Jiaxin Liu, i wsp.
Wydane: (2024-11-01)

MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma
od: Shouhua Zhang, i wsp.
Wydane: (2023-01-01)

Study on Sensing Performance of MDM Waveguide Coupled with the Square Cavity Containing a Rectangular Groove
od: WANG Cai-yun, i wsp.
Wydane: (2022-08-01)

Primary Cardiac Intimal Sarcoma: Multi-Layered Strategy and Core Role of <em>MDM2</em> Amplification/Co-Amplification and <em>MDM2</em> Immunostaining
od: Claudiu Nistor, i wsp.
Wydane: (2024-04-01)

Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways
od: Wei Wang, i wsp.
Wydane: (2025-02-01)